by Bruce Sylvester – New “real world” data suggests that the efficacy of Remsima® (infliximab), a biosimilar monoclonal antibody (mAb) anti-TNF-alpha agent approved by the European Commission, is… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.
by Gary Finnegan – The European Medicines Agency (EMA) is reviewing the cardiovascular risks of systemic ibuprofen medicines. The focus is expected to be on tablets taken by… read more.
by Gary Finnegan – The EU medicines regulator has rejigged its plan on how clinical trial data will be shared with health professionals, after intense lobbying by doctors,… read more.
by Gary Finnegan – The European Medicines Agency is drawing up a list of legally-operating online pharmacies as part of an EU-wide crackdown on falsified medicines.
Significant survival benefit observed in women with HER2 negative breast cancer – ASCO Press Release.
EMA Highlights by Gary Finnegan – At its April meeting, the EMA’s influential Committee for Medicinal Products for Human Use (CHMP) recommended that a marketing authorisation be granted… read more.
EMA Highlights by Gary Finnegan – The number of new medicines approved in the European Union is rising year-on-year, according to the European Medicines Agency (EMA).
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
